Journal: Cancer Research
Article Title: Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation
doi: 10.1158/0008-5472.CAN-23-2654
Figure Lengend Snippet: Pik3c3 is a therapeutic vulnerability of dormant cancer cells in a HER2 breast cancer model. A, Schematic for the MMTV-rtTA;TetO-Her2 and the origin of the primary and recurrent lines. doub, population doubling; dox, doxycycline; T0, reference time point; T-End, endpoint. B, Schematic for the CRISPR screen performed in the primary and recurrent MMTV-rtTA;TetO-Her2 cells. C, Graphs demonstrating the identification of Pik3c3 as a recurrent cell-specific fitness gene, as defined by the FDR and fold change of its gRNA(s) in the screens’ endpoint in reference to T0 (see Supplementary Methods for details). D, Venn diagram highlighting the number of identified recurrent cell-exclusive fitness genes. E, Cell viability assay comparing the sensitivity of primary and recurrent MMTV-rtTA;TetO-Her2 cells to VPS34IN1. AUC was quantified for each line and all lines’ sensitivity to VPS34IN1 was statistically different. F, Schematic for a cell death assay investigating the effect of VPS34IN1 (10 μmol/L) on the 54074 primary cells either during proliferation (in prescence of doxycycline) or dormancy (cells deprived of doxycycline). G, Quantifications of the percentage of dead 54074 cells after 24 and 48 hours treatment with VPS34IN1.
Article Snippet: The mouse Genome-Scale CRISPR Knockout (mGeCKO) library A (Addgene, #1000000052), composed of ∼68,000 guide RNAs (gRNA): 3 gRNAs/gene, 4 gRNAs/miRNA, and 1,000 nontargeting sequences, was amplified and prepared for next-generation sequencing (NGS; MiSeq Illumina) to assess the gRNA distribution and library quality, as previously described ( ).
Techniques: CRISPR, Viability Assay